Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4

Recall Number: D-0476-2017

Firm: Actavis Inc

Classification: Class II

Status: Terminated

Report Date: 20170222

Initiation Date: 20170130

Termination Date: 20180313

Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.

Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4